11/25
01:54 pm
neo
NeoGenomics (NASDAQ:NEO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
NeoGenomics (NASDAQ:NEO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/18
01:18 pm
neo
NeoGenomics (NASDAQ:NEO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
NeoGenomics (NASDAQ:NEO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/12
01:27 pm
neo
NeoGenomics (NASDAQ:NEO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
NeoGenomics (NASDAQ:NEO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/10
06:58 am
neo
1 Small-Cap Stock for Long-Term Investors and 2 We Brush Off [Yahoo! Finance]
Medium
Report
1 Small-Cap Stock for Long-Term Investors and 2 We Brush Off [Yahoo! Finance]
11/7
01:14 am
neo
NeoGenomics (NASDAQ:NEO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
NeoGenomics (NASDAQ:NEO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/6
07:05 am
neo
NeoGenomics to Participate in Upcoming Investor Conferences
Low
Report
NeoGenomics to Participate in Upcoming Investor Conferences
10/30
12:51 pm
neo
NeoGenomics to Present RaDaR ST Bridging Study at ISLB 2025, Demonstrating Reliable MRD Detection Across Solid Tumors
Medium
Report
NeoGenomics to Present RaDaR ST Bridging Study at ISLB 2025, Demonstrating Reliable MRD Detection Across Solid Tumors
10/30
09:32 am
neo
NeoGenomics (NEO): Losses Widen, Profitability Still Elusive as Revenue Trails Market Growth [Yahoo! Finance]
Medium
Report
NeoGenomics (NEO): Losses Widen, Profitability Still Elusive as Revenue Trails Market Growth [Yahoo! Finance]
10/28
06:02 pm
neo
NeoGenomics (NASDAQ:NEO) was given a new $14.00 price target on by analysts at Leerink Partners.
Medium
Report
NeoGenomics (NASDAQ:NEO) was given a new $14.00 price target on by analysts at Leerink Partners.
10/28
07:05 am
neo
NeoGenomics Reports Third Quarter 2025 Results
Medium
Report
NeoGenomics Reports Third Quarter 2025 Results
10/14
07:21 am
neo
NeoGenomics to Highlight RaDaR ST MRD Assay at ESMO Congress 2025 [Yahoo! Finance]
Low
Report
NeoGenomics to Highlight RaDaR ST MRD Assay at ESMO Congress 2025 [Yahoo! Finance]
10/14
07:05 am
neo
NeoGenomics to Highlight RaDaR ST MRD Assay at ESMO Congress 2025
Low
Report
NeoGenomics to Highlight RaDaR ST MRD Assay at ESMO Congress 2025
10/8
12:30 pm
neo
NeoGenomics (NASDAQ:NEO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
NeoGenomics (NASDAQ:NEO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
10/7
07:05 am
neo
NeoGenomics to Report Third Quarter 2025 Financial Results on October 28, 2025
Low
Report
NeoGenomics to Report Third Quarter 2025 Financial Results on October 28, 2025
10/2
04:00 pm
neo
agilon health, Tandem Diabetes, NeoGenomics, Hims & Hers Health, and Oscar Health Stocks Trade Up, What You Need To Know [Yahoo! Finance]
Low
Report
agilon health, Tandem Diabetes, NeoGenomics, Hims & Hers Health, and Oscar Health Stocks Trade Up, What You Need To Know [Yahoo! Finance]
9/28
07:41 am
neo
NeoGenomics (NEO): Exploring Current Valuation After Recent Share Price Volatility [Yahoo! Finance]
Medium
Report
NeoGenomics (NEO): Exploring Current Valuation After Recent Share Price Volatility [Yahoo! Finance]
9/24
09:20 am
neo
Here's Alger Weatherbie Specialized Growth Fund's Comment on NeoGenomics (NEO) [Yahoo! Finance]
Low
Report
Here's Alger Weatherbie Specialized Growth Fund's Comment on NeoGenomics (NEO) [Yahoo! Finance]
9/16
12:09 pm
neo
NeoGenomics (NASDAQ:NEO) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Low
Report
NeoGenomics (NASDAQ:NEO) had its "buy" rating reaffirmed by analysts at Cowen Inc.
9/14
10:00 am
neo
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEO
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEO
9/13
10:00 am
neo
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEO
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEO
9/12
09:57 am
neo
NeoGenomics (NASDAQ:NEO) had its price target raised by analysts at TD Cowen from $10.00 to $12.00. They now have a "buy" rating on the stock.
Medium
Report
NeoGenomics (NASDAQ:NEO) had its price target raised by analysts at TD Cowen from $10.00 to $12.00. They now have a "buy" rating on the stock.
9/12
04:44 am
neo
1 Safe-and-Steady Stock Worth Your Attention and 2 We Ignore [Yahoo! Finance]
Medium
Report
1 Safe-and-Steady Stock Worth Your Attention and 2 We Ignore [Yahoo! Finance]
9/11
07:40 am
neo
Laborie Appoints Chris Smith as Chief Executive Officer [Yahoo! Finance]
Low
Report
Laborie Appoints Chris Smith as Chief Executive Officer [Yahoo! Finance]
9/10
04:46 pm
neo
Why NeoGenomics (NEO) Shares Are Falling Today [Yahoo! Finance]
High
Report
Why NeoGenomics (NEO) Shares Are Falling Today [Yahoo! Finance]
9/10
02:50 pm
neo
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEO
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEO